Latest Market News

Sarama Resources has successfully closed the first tranche of a A$2.7 million equity placement to fund exploration at its Cosmo Gold Project and support ongoing arbitration efforts. The second tranche, involving options and director participation, awaits shareholder approval.

ikeGPS Group Limited has announced a fully underwritten A$18 million placement and a A$2 million share purchase plan to fund new product development and expand its market leadership in North America's utility software sector.

Betashares Capital Ltd has released the estimated annual distribution components for its 28BB Fixed Term Corporate Bond Active ETF, signalling a 31% attributed income and a full cash payout for the 2024-25 financial year.

ASX Compliance has formally questioned Rewardle Holdings Limited over delayed disclosures, financial inconsistencies, and governance concerns tied to its investments in Pepper Leaf, Beanhunter, and CloudHolter.

Ashley Services Group reports a slight dip in FY25 EBITDA amid Victorian project delays and funding cuts, opting to suspend dividends to focus on debt reduction and future growth.

Emperor Energy has raised $3.7 million through a share placement to advance the Judith-2 appraisal well in Victoria’s Gippsland Basin, backed by independent resource validation and strategic infrastructure proximity.

Mineral Commodities Ltd updates investors on the delayed sale of its Skaland Graphite Project, with Norge Mineraler making significant non-refundable payments and committing to complete the transaction by the end of July.

Finbar Group has acquired the Palmyra development site from its JV partner, transforming it into a wholly-owned project valued at $88 million with settlement expected in early 2026.

InteliCare Holdings has raised $1 million through a structured financing deal to extend its cash runway and scale its AI-driven healthcare platform across aged care and disability sectors.

Biome Australia Limited has confirmed its record FY25 sales revenue of approximately $18.4 million, marking a 41% increase year-on-year, while affirming full compliance with ASX continuous disclosure rules.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Nanoveu Limited has showcased its acquisition of EMASS and the breakthrough ECS-DoT system-on-chip technology, promising ultra-low-power AI processing with a notable 33% simulated flight time improvement in drones.